top of page
Search

PCOS Has a New Name. Here's What It Means for You.


By Amanda Queen, PA-C


The condition you know as PCOS has been renamed. Here's why it matters.


If you've been diagnosed with Polycystic Ovary Syndrome, or suspect you might have it, you may have already noticed that the name never quite fit. "Polycystic" puts ovarian cysts at the center of the story. But for most women living with this condition, cysts aren't even part of the picture.


That disconnect isn't just confusing, but has contributed to years of delayed diagnoses, dismissed symptoms, and a narrow view of what's actually going on. Those of us in integrative and functional medicine have long understood this is truly a metabolic issue, rather than a combo of irregular cycles and cyst formation. 


The new name is Polyendocrine Metabolic Ovarian Syndrome (PMOS), and it tells a much more accurate story.[1]



What is PMOS, exactly?


PMOS is a systemic hormonal and metabolic condition. The updated name breaks it down clearly:[2]


- Polyendocrine: multiple hormone systems are involved, not just the ovaries.


- Metabolic: the body's ability to regulate blood sugar, energy, and weight is also affected.


In other words, your ovaries aren't the source of the problem. They're responding to a system under stress.[3]



The symptoms are broader than you've been told


If you've been living with any combination of the following, your body may have been trying to tell you something for a long time:


- Irregular or missing periods


- Insulin resistance


- Weight management challenges


- Acne


- Excess hair growth (hirsutism)


- Anxiety and depression[4]


- Brain fog


- Fatigue


These symptoms span hormonal, metabolic, and neurological pathways, which is exactly why a name that focused only on ovarian cysts was never going to lead to the right answers.



The scale of the problem


An estimated 1 in 8 women are affected by this condition, and the average diagnosis still takes years.[5][6] Why? Because providers were often looking for the wrong things or dismissing symptoms altogether.


The rename is a meaningful step toward faster, more accurate recognition. But the name change alone doesn't change the care. That part still has to catch up.



Why integrative and functional medicine matters here


Conventional care has often offered one primary answer: hormonal birth control. And while contraception can manage certain symptoms, PMOS affects hormones, metabolism, blood sugar regulation, and mood simultaneously. Not only do hormonal contraceptives not address the remaining concerns, they may actually make them worse.[7]


The international evidence-based guidelines now recommend a multi-pronged approach. Lifestyle modification, metabolic management, and psychological screening, alongside any pharmacological treatment. Nutritional and complementary strategies such as inositols, vitamin D, and mind-body practices are also being studied as potential adjuncts.[7][8]


An integrative approach looks at how those systems are interacting in your body specifically - not a one-size-fits-all protocol, but a full picture of what's driving your symptoms and what your body actually needs.



If this resonates with you


If you've been diagnosed with PCOS/PMOS, told birth control is your only option, or spent years feeling like something is off without getting clear answers, you're not imagining it. The science is catching up to what you've been experiencing.


And, there are more options than you've been offered.


At Revival Integrative Health, we work with women navigating PMOS every day. If you'd like to explore what a more complete approach could look like for you, we'd love to talk.






References

  1. Polyendocrine Metabolic Ovarian Syndrome, the New Name for Polycystic Ovary Syndrome: A Multistep Global Consensus Process. Teede HJ, Khomami MB, Morman R, et al. Lancet (London, England). 2026;407(10545):2329-2339. doi:10.1016/S0140-6736(26)00717-8.

  2. PCOS Is Now PMOS—Will a New Name Translate to Improved Clinical Care?. Kate Schweitzer. JAMA. 2026. doi:10.1001/jama.2026.10402.

  3. European Society of Gynecology (ESG) Position Paper on the Proposed Terminology Change From PCOS to PMOS. Castelo-Branco C, Vujovic S, Genazzani AD, et al. Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology. 2026;42(1):2695512. doi:10.1080/09513590.2026.2695512.

  4. Prevalence of Polycystic Ovary Syndrome: A Global and Regional Systematic Review and Meta-Analysis. Neven ACH, Forslund M, Ranasinha S, et al. Human Reproduction Update. 2026;32(3):277-312. doi:10.1093/humupd/dmaf030.

  5. Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Teede HJ, Tay CT, Laven JJE, et al. The Journal of Clinical Endocrinology and Metabolism. 2023;108(10):2447-2469. doi:10.1210/clinem/dgad463.

  6. Polycystic Ovary Syndrome. McCartney CR, Marshall JC. The New England Journal of Medicine. 2016;375(1):54-64. doi:10.1056/NEJMcp1514916.

  7. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic Ovary Syndrome: The Impact of Androgen Excess on Metabolic Health. Cussen L, McDonnell T, Miller C, McIlroy M, O'Reilly MW. Reproduction (Cambridge, England). 2025;170(2):e250102. doi:10.1530/REP-25-0102.

  8. Comprehensive Transition of Care for Polycystic Ovary Syndrome From Adolescence to Adulthood. Simon SL, Phimphasone-Brady P, McKenney KM, et al. The Lancet. Child & Adolescent Health. 2024;8(6):443-455. doi:10.1016/S2352-4642(24)00019-1.

 
 
 

Comments


bottom of page